⌘K

Login Start Free

Home/Filings/4/0000875320-25-000179

4//SEC Filing

Lagarde Michel 4

Accession 0000875320-25-000179

CIK 0000875320other

View on SEC.gov Company Profile

Filed

May 4, 8:00 PM ET

Accepted

May 5, 4:20 PM ET

Size

5.1 KB

Accession

0000875320-25-000179

Insider Transaction Report

Form 4

Period: 2025-05-01

VERTEX PHARMACEUTICALS INC / MAVRTX

Director

Transactions

Award
Stock Option (Right to Buy)
2025-05-01+2,398→ 2,398 total
Exercise: $502.97Exp: 2035-04-30→ Common Stock (2,398 underlying)

Footnotes (1)

[F1]Fully vested.

Documents

1 file

4
wk-form4_1746476447.xmlPrimary
FORM 4

Issuer

VERTEX PHARMACEUTICALS INC / MA

CIK 0000875320

Entity typeother

Related Parties

1

filerCIK 0001518973

Filing Metadata

Form type: 4
Filed: May 4, 8:00 PM ET
Accepted: May 5, 4:20 PM ET
Size: 5.1 KB

View on SEC.gov